Report cover image

U.S. In-Vitro Diagnostics Market - Focused Insights 2024-2029

Publisher Arizton Advisory and Intelligence
Published Apr 08, 2024
Length 115 Pages
SKU # ARZ18681702

Description

U.S. In-Vitro Diagnostics Market - Focused Insights 2024-2029


The U.S. in-vitro diagnostics (IVDs) market is expected to grow at a CAGR of 1.63% from 2023-2029.

MARKET DRIVERS

Growing Importance of IVD In Healthcare: The technological innovation and its application in healthcare are leading to the practical implementation of new treatment methods. The expectations for personalized medicine are growing, wherein medication and treatment are tailored to each patient's unique characteristics and medical condition. Testing is likely to play an increasingly important role in healthcare, as the realization of personalized medicine will require testing to confirm individual characteristics. For instance, cancer genomic medicine, which has begun earnestly, requires analysis of genetic information within cancer cells through genetic testing. Sysmex is working to achieve this type of cancer genomic medicine and to make liquid biopsy a reality.

Increasing Adoption Of Automation in Laboratories: Integrating automation into the IVD manufacturing process has many benefits for IVD device designers and manufacturers. Automation allows for the inclusion of software-based calculation, calibration, and documentation, improving test efficiency, calibration schedules, regulatory compliance, and instrument/equipment traceability. These benefits reduce labor, lower error (standardization) risk, and fewer calibration tests. Furthermore, automated volumetric measurements simplify production fabrication processes by giving manufacturers better control over manufacturing equipment and steps in the production line.

U.S. IN-VITRO DIAGNOSTICS MARKET HIGHLIGHTS
  • The reagents and consumables product segment occupies a major market share of over 67% in the U.S. in-vitro diagnostics (IVDs) market. Reagents and consumables are used in in-vitro diagnostics procedures as a medium and transporter of specimens. With the increasing adoption of in-vitro diagnostics solutions, the demand for reagents and consumables is increasing. Infectious diseases and pandemics such as COVID-19 significantly fuel the demand for reagents in diagnosis.
  • By technology, the hematology segment is growing significantly, with the highest CAGR of 3.05% during the forecast period. The growth of the segment is attributed to the increasing incidences of blood disorders and other diseases, rapid technological advances in hematology, and the emergence of high-throughput hematology analyzers.
  • The diabetes application segment is propelling, with the fastest-growing CAGR in the U.S. market during the forecast period. The rising health consciousness among the population and the demand for diabetes monitoring devices, coupled with the easy availability of advanced diabetes devices, are fostering market growth in this country.
  • The standard reference labs segment dominated the market share of the U.S. in-vitro diagnostics market. The segmental growth is primarily due to impeccable quality control standards, delivering top-tier testing services to hospitals, clinics, and various public and private healthcare institutions. Standard reference laboratories majorly contribute to the in-vitro diagnostics (IVD) market. These facilities undertake multiple responsibilities and a broad network of labs across regions. They are adept at conducting intricate and high-risk tests for many purposes.
VENDOR LANDSCAPE

The U.S. in-vitro diagnostics (IVDs) market report contains exclusive data on 83 vendors. The competition among market players in the IVD market is significantly high for products, solutions, reagents, consumables, and services in terms of pricing, product, and associated brand image, services, and associated quality, a new product launched and developed, customer services, and financing terms. The leading market players in the US IVD market are F Hoffmann-La Roche, Abbott, Thermo Fisher Scientific, Diasorin, Biomerieux, Danaher, Bio-Rad, and Siemens Healthineers, competing with rapidly emerging market players. Vendors in the market are increasing their market share through inorganic growth strategies.

REPORT HIGHLIGHTS

SEGMENTATION & FORECAST
  • Products & Services
  • Reagents and Consumables
  • Instruments/Analyzers & Software
  • Services
  • Technology
  • Immuno and Clinical Chemistry
  • Molecular Diagnostics
  • Hematology
  • Microbiology and Cytology
  • Others
  • Application
  • Infectious Diseases
  • Diabetes
  • Cardiology
  • Oncology
  • Autoimmune Diseases
  • Nephrology
  • Drug Testing
  • Others
  • End-Users
  • Standard reference labs
  • Hospital Affiliated Labs
  • Individuals
  • Clinics
  • Others
Vendors List

Key Vendors
  • Abbott Laboratories
  • bioMerieux
  • Danaher
  • Roche
  • Bio-Rad
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Diasorin
Other Prominent Vendors
  • Qiagen
  • Quest Diagnostics
  • Atomo Diagnostics
  • Sysmex Corp
  • Accelerate Diagnostics
  • Arkray Inc
  • Agilent Technologies
  • BD
  • Illumina
  • Mindray
  • Revvity
  • Grifols
  • Hologic
  • Amoy Diagnostics
  • Altona
  • Cepheid
  • Exact Sciences
  • Beckman Coulter
  • QuidelOrtho
  • Tosoh
  • Myriad Genetics
  • AccuBio Tech
  • Agappe Technologies
  • Balio Diagnostics
  • B&E BIO-TECHNOLOGY
  • bioLytical Laboratories
  • Biosynex
  • Biocartis
  • Biocept
  • Biomerica
  • Boule Diagnostics
  • Cupid
  • Caredx
  • Chembio Diagnostics
  • Clindiag Systems
  • Contec Medical Systems
  • CellaVision
  • Dialab
  • Dexcom
  • Diagon
  • Diatron
  • Dirui
  • Drucker Diagnostics
  • EDAN Instruments
  • EKF Diagnostics Holding
  • ELITechGroup
  • Erba Diagnostics
  • Genrui Biotech
  • High Technology
  • Horiba
  • Linear Chemicals
  • INTEC
  • J. Mitra & Co.
  • Maccura Biotechnology
  • Medsource ozone Biomedicals
  • Meril Life Sciences
  • MP Biomedicals
  • NIHON KOHDEN
  • Norma
  • NOWDiagnostics
  • OPKO Health
  • OraSure Technologies
  • Perkin Elmer
  • Prestige Diagnostics
  • Seasun Biomaterials
  • Sekisui Diagnostics
  • SFRI
  • Shenzhen Dymind Biotechnology
  • Shenzhen Landwind Medical
  • Sinocare
  • Spinreact
  • The Binding Site Group
  • Trinity Biotech
  • Trivitron Healthcare
  • Trividia Health
KEY QUESTIONS ANSWERED:

1. How big is the U.S. in-vitro diagnostics (IVDs) market?

2. What are the key trends in the U.S. in-vitro diagnostics (IVDs) market?

3. Who are the major players in the U.S. in-vitro diagnostics (IVDs) market?

4. What is the growth rate of the U.S. in-vitro diagnostics (IVDs) market?

Table of Contents

115 Pages
CHAPTER – 1: In-Vitro Diagnostics Market Overview
Executive Summary
Key Findings
CHAPTER – 2: In-Vitro Diagnostics Market
US: Projected Revenue of In-Vitro Diagnostics Market (2020-2029; $Billions)
CHAPTER – 3: In-Vitro Diagnostics Market Segmentation Data
US: Projected Revenue by Products & Services (2020-2029; $Billions)
Reagents and Consumables
Instruments/Analyzers & Software
Services
US: Projected Revenue by Technology (2020-2029; $Billions)
Immuno and Clinical Chemistry
Molecular Diagnostics
Hematology
Microbiology and Cytology
Others
US: Projected Revenue by Application (2020-2029; $Billions)
Infectious Diseases
Diabetes
Cardiology
Oncology
Auto Immune Diseases
Nephrology
Drug Testing
Others
US: Projected Revenue by End-Users (2020-2029; $Billions)
Standard Reference Labs
Hospital Affiliated Labs
Individuals
Clinics
Others
CHAPTER – 4: In-Vitro Diagnostics Market Prospects & Opportunities
In-Vitro Diagnostics Market Opportunities & Trends
In-Vitro Diagnostics Market Drivers
In-vitro diagnostics Constraints
CHAPTER – 5: In-Vitro Diagnostics Industry Overview
In-Vitro Diagnostics Market - Competitive Landscape
In-Vitro Diagnostics Market – Key Vendor Profiles
In-Vitro Diagnostics Market - Other Prominent Vendors
In-Vitro Diagnostics Market - Key Strategic Recommendations
CHAPTER – 6: Appendix
Research Methodology
Abbreviations
About Arizton
LIST OF EXHIBITS
Exhibit 1: Projected Revenue of In-vitro Diagnostics in US (2020-2029; $ Bn)
Exhibit 2: Market Size & Forecast – Reagents and Consumables (2020-2029; $ Bn)
Exhibit 3: Market Size & Forecast – Instruments/Analyzers & Software (2020-2029; $ Bn)
Exhibit 4: Market Size & Forecast – Services (2020-2029; $ Bn)
Exhibit 5: Market Size & Forecast – Immuno and Clinical Chemistry (2020-2029; $ Bn)
Exhibit 6: Market Size & Forecast – Molecular Diagnostics (2020-2029; $ Bn)
Exhibit 7: Market Size & Forecast – Hematology (2020-2029; $ Bn)
Exhibit 8: Market Size & Forecast – Microbiology and Cytology (2020-2029; $ Bn)
Exhibit 9: Market Size & Forecast – Other (2020-2029; $ Bn)
Exhibit 10: Market Size & Forecast – Infectious Diseases (2020-2029; $ Bn)
Exhibit 11: Market Size & Forecast – Diabetes (2020-2029; $ Bn)
Exhibit 12: Market Size & Forecast – Cardiology (2020-2029; $ Bn)
Exhibit 13: Market Size & Forecast – Oncology (2020-2029; $ Bn)
Exhibit 14: Market Size & Forecast – Autoimmune Diseases (2020-2029; $ Bn)
Exhibit 15: Market Size & Forecast – Nephrology (2020-2029; $ Bn)
Exhibit 16: Market Size & Forecast – Drug Testing (2020-2029; $ Bn)
Exhibit 17: Market Size & Forecast – Others (2020-2029; $ Bn)
Exhibit 18: Market Size & Forecast – Standard Reference Labs (2020-2029; $ Bn)
Exhibit 19: Market Size & Forecast – Hospital-Affiliated Labs (2020-2029; $ Bn)
Exhibit 20: Market Size & Forecast – Individuals (2020-2029; $ Bn)
Exhibit 21: Market Size & Forecast – Clinics (2020-2029; $ Bn)
Exhibit 22: Market Size & Forecast – Others (2020-2029; $ Bn)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us